C. Ryle et al., NONENZYMATIC GLYCATION OF PERIPHERAL AND CENTRAL-NERVOUS-SYSTEM PROTEINS IN EXPERIMENTAL DIABETES-MELLITUS, Muscle & nerve, 20(5), 1997, pp. 577-584
Nonenzymatic glycation of neural proteins could underlie diabetic peri
pheral neuropathy. Cytoskeletal and myelin protein fractions of centra
l nervous system and peripheral nervous system (PNS) tissue from rats
with streptozotocin-induced diabetes of 1.5 and 8 months duration were
analyzed for glycation products. In sciatic nerve cytoskeletal prepar
ations from both diabetic and control animals we found high levels of
the early glycation product (measured as furosine) after 6 weeks, whic
h had fallen markedly by 8 months. Conversely the advanced glycation e
nd product (AGE), pentosidine, was low at 6 weeks and high by 8 months
in diabetic animals. The levels of glycation products were much lower
in spinal cord and spinal nerve from diabetic animals. There was incr
eased borotritride labeling of neurofilament subunits, and of cross-li
nked material, in cytoskeletal fractions of diabetic sciatic nerves. T
hese results show that the PNS cytoskeleton is vulnerable to nonenzyma
tic glycation, resulting in AGE formation, in diabetic rats and to a l
esser extent in normals. (C) 1997 John Wiley & Sons, Inc.